Prior Auth Required

0332U - probability of responding to immune checkpoint-inhibitor therapy

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Serviceprobability of responding to immune checkpoint-inhibitor therapy
Procedure / Service Description

Myocardial sympathetic innervation imaging, planar qualitative and quantitative assessment; - Oncology (pan-tumor), genetic profiling of 8 DNA-regulatory (epigenetic) markers by quantitative polymerase chain reaction (qPCR), whole blood, reported as a high or low 0332U probability of responding to immune checkpoint-inhibitor therapy Oncology (liver), surveillance for hepatocellular carcinoma (HCC) in high-risk patients, analysis of methylation patterns on circulating cell-free DNA (cfDNA) plus measurement of

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.